Feedback / Questions
autologous humanized anti-CD22 chimeric antigen receptor T cells - Beijing Boren Hospital
http://clinicaltrials.gov/ct2/show/NCT04340167
Apr 9, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next